These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3414330)

  • 41. Collagen degradation in the pregnant human cervix at term and after prostaglandin-induced cervical ripening.
    Rath W; Adelmann-Grill BC; Pieper U; Kuhn W
    Arch Gynecol; 1987; 240(3):177-84. PubMed ID: 3036024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of prostaglandins on the lysosomal function in the cervix uteri.
    Joh K; Riede UN; Zahradnik HP
    Arch Gynecol; 1983; 234(1):1-16. PubMed ID: 6660924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Facilitation of cervical dilatation by intracervical application of sulprostone gel prior to hysteroscopy.
    Rath W; Kuhn W; Hilgers R
    Endoscopy; 1985 Sep; 17(5):191-3. PubMed ID: 4054064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal serum hormone changes during abortion induced with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester.
    Bremme K; Eneroth P; Bygdeman M
    Prostaglandins Leukot Med; 1982 Jun; 8(6):647-51. PubMed ID: 6955815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
    Jansen NE; Pasker-De Jong PC; Zondervan HA
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):847-51. PubMed ID: 18979392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH; Graves ZR
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin E2-induced ripening of the human cervix involves changes in proteoglycan metabolism.
    Norman M; Ekman G; Malmström A
    Obstet Gynecol; 1993 Dec; 82(6):1013-20. PubMed ID: 8233252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical changes in human cervical connective tissue after intracervical application of prostaglandin E2.
    Rath W; Osmers R; Adelmann-Grill BC; Stuhlsatz HW; Szevereny M; Kuhn W
    Prostaglandins; 1993 Apr; 45(4):375-84. PubMed ID: 8493359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Stoutjesdijk JA; Alsma J; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative cervical priming by intracervical application of a new sulprostone gel.
    Rath W; Dennemark N; Gödicke HD
    Contraception; 1985 Mar; 31(3):207-16. PubMed ID: 3995960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Termination of second trimester pregnancy with laminaria and intramuscular 16 phenoxy-omega-17, 18, 19, 20 tetranor PGE2 methylsulfonylamide (sulprostone)-A randomised study.
    Karim SM; Ratnam SS; Lim AL; Yeo KC; Choo HT
    Prostaglandins; 1982 Feb; 23(2):257-63. PubMed ID: 7043657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. IV. Possible modalities of its use in gynecology].
    Stoppelli I; Piras G; Dessole S
    Minerva Ginecol; 1983 Dec; 35(12):833-4. PubMed ID: 6672685
    [No Abstract]   [Full Text] [Related]  

  • 55. [The use of sulprostone for voluntary interruption of gestation and in intrauterine fetal death].
    Di Meglio L; Malagnino F; Ballerini M; Mocchia M
    Minerva Ginecol; 1990 Mar; 42(3):75-8. PubMed ID: 2338963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical trial of pregnancy terminations in 353 patients where amenorrhea was present for less than 49 days by 600 mg of RU 486 (administered orally) and 500 mg of sulprostone (Nalador) administered intramuscularly].
    Aubeny E; Bureau A; Gabeaud P; Heard I; Eucher M; Husson T; Meng L; Riotte S
    Fertil Contracept Sex; 1989 Apr; 17(4):307-14. PubMed ID: 12282175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of sulprostone in the medical evacuation of uterine contents].
    Paulo AS; Reis-Morais AC; Sá-Correia M
    Acta Med Port; 1996; 9(4-6):157-61. PubMed ID: 9005689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical effects and cervical tissue changes after treatment with 16,16 dimethyl-trans delta 2 PGE1 methylester in the first trimester.
    Ding JQ; Granberg S; Norström A
    Prostaglandins; 1990 Mar; 39(3):281-5. PubMed ID: 2339200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical ripening in guinea-pigs after a local application of nitric oxide.
    Chwalisz K; Shao-Qing S; Garfield RE; Beier HM
    Hum Reprod; 1997 Oct; 12(10):2093-101. PubMed ID: 9402261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prostaglandin premedication in evacuation of the uterus in the first trimester].
    Döring GK; Olbrich L; Schmitt B
    Fortschr Med; 1988 May; 106(15):313-6. PubMed ID: 3402880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.